Secretory IgA in breast milk protects against asthma through modulation of the gut microbiota

Cell Rep. 2024 Oct 22;43(10):114835. doi: 10.1016/j.celrep.2024.114835. Epub 2024 Oct 4.

Abstract

Asthma susceptibility is linked to dysbiosis in early-life gut microbiota, and the antibody secretory immunoglobulin (Ig)A (SIgA) is a key determinant of gut microbiota composition. SIgA is obtained through breast milk during the critical early-life window. We use a mouse model of SIgA deficiency and the house dust mite (HDM) model of asthma to elucidate the role of maternal SIgA in modulating the early-life gut microbiota and asthma protection. Mice that do not receive maternal SIgA display a transient bloom of segmented filamentous bacteria (SFB) in the small intestine during the early post-weaning period. Mice that do not receive maternal SIgA also display elevated T helper type 17 (Th17) cell activation in the intestine, which persists into adulthood and is associated with more severe inflammation in response to the HDM model of asthma. This study demonstrates a mechanism by which breast-milk-derived SIgA influences immune development and asthma susceptibility by modulating the early-life gut microbiota.

Keywords: CP: Immunology; CP: Microbiology; breast milk antibodies; early-life gut microbiota; immune development; secretory IgA; segmented filamentous bacteria.

MeSH terms

  • Animals
  • Asthma* / immunology
  • Asthma* / microbiology
  • Disease Models, Animal
  • Female
  • Gastrointestinal Microbiome* / immunology
  • Humans
  • Immunoglobulin A, Secretory* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Milk / immunology
  • Milk, Human / immunology
  • Pyroglyphidae / immunology
  • Th17 Cells / immunology

Substances

  • Immunoglobulin A, Secretory